Drug Shortage Report for TIAZAC XC

Last updated on 2019-09-13 History
Report ID 93532
Drug Identification Number 02256754
Brand name TIAZAC XC
Common or Proper name TIAZAC XC
Company Name VALEANT CANADA LP/VALEANT CANADA S.E.C.
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 240MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size n/a
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Demand increase for the drug.
Anticipated start date 2019-09-12
Actual start date
Estimated end date
Actual end date 2019-09-11
Shortage status Avoided shortage
Updated date 2019-09-13
Company comments
Health Canada comments
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-09-13 French Compare
v5 2019-09-13 English Compare
v4 2019-09-13 English Compare
v3 2019-09-13 English Compare
v2 2019-09-10 French Compare
v1 2019-09-10 English Compare